Jury Selected for Latest Malpractice Case Against Spine Doctor
Jury Selected for Latest Malpractice Case Against Spine Doctor
Jury Selected for Latest Malpractice Case Against Spine Doctor
Drug Companies Try to Hijack $4 Billion, Reduce Medicare Discounts
Young People Still Need Medication for Addiction Treatment, Study Suggests
Prescription Data May Underestimate Concurrent Use of Opioids and Benzodiazepines
Medical Training for Addiction is Still Mostly Unchartered Territory
Letters Sent to Physicians to Curtail Opioid Epidemic
A Large Number of Opioids Prescribed Without a Documented Reason
Vermont is the latest state to sue Connecticut-based Purdue Pharma L.P. over its opioid drug, OxyContin, joining many others in the fight against the large manufacturer for sparking a nationwide epidemic. The state is accusing the company of using deceptive marketing practices to advertise its painkillers as an appropriate treatment for chronic pain. Vermont Attorney
The University of Michigan Health System (UMHS) has agreed to pay the United States $4.3 million to settle a lawsuit involving allegations of drug diversion violating certain provisions of the Controlled Substances Act, the statute establishing federal U.S. drug policy under which the manufacture, importation, possession, use, and distribution of certain substances, including prescription drugs, is
Makers of e-Cigs, Liquid Vapes Potentially Targeting Children Pull Products